Well-characterized genetic parts are necessary for the design of novel genetic circuits. Here we describe a cost-effective, high-throughput method for rapidly characterizing genetic parts. Our method reduces cost and time by combining cell-free lysates, linear DNA to avoid cloning, and acoustic liquid handling to increase throughput and reduce reaction volumes.
Characterizing and cataloging genetic parts are critical to the design of useful genetic circuits. Having well-characterized parts allows for the fine-tuning of genetic circuits, such that their function results in predictable outcomes. With the growth of synthetic biology as a field, there has been an explosion of genetic circuits that have been implemented in microbes to execute functions pertaining to sensing, metabolic alteration, and cellular computing. Here, we show a rapid and cost-effective method for characterizing genetic parts. Our method utilizes cell-free lysate, prepared in-house as a medium to evaluate parts via the expression of a reporter protein. Template DNA is prepared by PCR amplification using inexpensive primers to add variant parts to the reporter gene, and the template is added to the reaction as linear DNA without cloning. Parts that can be added in this way include promoters, operators, ribosome binding sites, insulators, and terminators. This approach, combined with the incorporation of an acoustic liquid handler and 384-well plates, allows the user to carry out high-throughput evaluations of genetic parts in a single day. By comparison, cell-based screening approaches require time-consuming cloning and have longer testing times due to overnight culture and culture density normalization steps. Further, working in cell-free lysate allows the user to exact tighter control over the expression conditions through the addition of exogenous components and DNA at precise concentrations. Results obtained from cell-free screening can be used directly in applications of cell-free systems or, in some cases, as a way to predict function in whole cells.
A core effort of synthetic biology is to develop genetic tool kits containing well-characterized parts, which can be used to construct genetic circuits1 that carry out useful functions when deployed in microbes or cell-free lysates. Areas in which such genetic circuits have gained traction are sensing2,3,4, human performance5,6, biofuels7,8, materials production9,10, and cellular computing11. Registries of standardized genetic parts have been established12 to catalog new and existing parts into categories such as promoters, operators, coding sequences, and terminators, to name just a few. Efforts such as the iGEM (international Genetically Engineered Machines) competition13 have been instrumental in characterizing and cataloging these genetic parts. Many methods have been developed to facilitate the rapid assembly of these parts into useful genetic circuits14,15. Software has even been developed to automate the composition of well-characterized parts into circuits that achieve a desired function16. However, the assembly of useful genetic circuits with predictable functions rests on the presumption that the genetic tool kits contain well-characterized genetic parts. Due to the necessity of these tool kits toward the advancement of synthetic biology, numerous efforts to better catalog circuits and parts with appropriate characterization data have been described17,18,19,20,21.
One approach to characterizing genetic components makes use of cell-free protein synthesis (CFPS) systems, which reconstitute cellular functions such as transcription and translation ex vivo22. Several studies have demonstrated the potential of CFPS for prototyping genetic components23,24,25,26,27,28,29,30,31,32 whether for direct applications in cell-free systems or to predict the function of genetic constructs in cells, such as the relative activity of parts within a library29, metabolic pathway optimization27, and cellular burden30. Advantages to prototyping in CFPS versus cells highlighted by these studies include avoiding time-consuming cloning, precise control over the concentration of DNA and other reaction components, and the ability to easily mix and match multiple DNA constructs. The advantage of avoiding cloning is especially apparent when using linear DNA templates, which enables new constructs to be assembled by in vitro methods that take hours instead of days33. The ability to manipulate the concentration of DNA constructs and other components simply by pipetting makes the approach even more attractive by enabling high-throughput experimentation powered by liquid handling robots34,35. While successes using CFPS for prototyping have been reported, it is important to note that it remains to be seen under what contexts CFPS results can reliably predict functionality in cells.
Here, we present a method for CFPS prototyping that emphasizes the advantages in speed, throughput, and cost compared to traditional cell-based approaches. The approach is derived from our previous work where we used CFPS to rapidly characterize a library of T7 promoter variants regulated by the transcription factor TetR32, significantly expanding on the small handful of regulated T7 promoter variants that were available in the literature at the time36,37. Others have, since then, further expanded the range of such promoters38. In our method, genetic construct assembly is accelerated by using PCR to amplify template DNA via primers that add variant genetic parts to a reporter gene. Acoustic liquid handling in 384-well plates is used to increase throughput and decrease the volume of materials required. Previous work has demonstrated successful use of acoustic liquid handling at significantly lower volumes39,40 with variability comparable to manual pipetting of larger volumes41. In addition to the method, we provide troubleshooting information and an assessment of potential cost and time savings. Note that while we include a protocol for producing cell-free lysates based on Sun et al.42 here, numerous other commercial kits and protocols43,44 should also work. Similarly, while we demonstrate the method for the characterization of promoter variants32, other parts can be interchanged by PCR amplification, such as riboregulators, Ribosome Binding Sites (RBSs), insulators, protein tags, and terminators. We hope that this methodology can help the synthetic biology community continue to grow the number of characterized parts for the assembly of predictable genetic circuits with useful function.
1. Preparation of cell extract
2. Linear template preparation
3. Purified protein preparation
4. Cell-free protein synthesis
To demonstrate the utility of our methods, we present results that describe the effects of proximity of the tetO sequence to the T7 promoter on the regulation of T7 RNAP-driven expression. The full results and their implications can be found in the work of McManus et al.32. The workflow is described in Figure 1. Fifteen linear templates, varying only in the distance of the T7 promoter relative to the tetO sequence, were prepared by PCR-amplifying the sfGFP reporter with primers designed to add each promoter variant (Figure 2) as described in section 2 of the protocol. CFPS reaction components and reactions were prepared following the protocol. The expression of sfGFP was measured from each template with a titration of 12 different concentrations of the TetR protein, in triplicate, using an acoustic liquid handler. At 36 CFPS reactions per template and 15 templates, a total of 540 reactions for the entire set of T7-tetO combinations were performed. The entire evaluation was carried out on two plates in two plate readers. Analysis of this data showed that the T7 RNAP downregulates T7-driven expression equally up through 13 bp downstream from the start of the T7 transcript (Figure 3). This result has implications for the future design of regulatable T7-driven gene circuits by describing a putative window for an effective repression of T7 by other repressors. Comparison of results from the protocol described here with DNA prepared by traditional cloning revealed a small but statistically significant difference in the degree of TetR repression between formats. We hypothesized that non-specific binding of TetR to the vector DNA could explain the observed difference. Experimental results showed that addition of linear vector DNA to reactions with linear template DNA reduced the difference to non-statistical significance, though it did not rule out contributions from other factors, such as differences in periodicity of the DNA helix for linear vs. circular formats, which, in turn, could affect TetR binding. Depending upon the application, the use of linear template may require additional validation.
We further include representative data on potential issues with accurate dispensing using acoustic liquid handling (Figure 4). A solution of 1x phosphate buffered saline (PBS), pH 7.4 containing 0.25 mM tartrazine dye was used to evaluate two methods of programming an acoustic liquid handler to dispense volumes >1 µL. Following liquid dispensing, the destination plate was sealed and centrifuged at 1,500 x g for 1 min, and the absorbance at 425 nm measured with a plate reader. Representative results of nine experiments are shown and demonstrate more consistent dispensing across the series of eight destination wells when the 5 µL transfer is divided into separate 1 µL dispenses. Based on these observations, it is recommended that transfers >1 µL be broken down into multiple transfers of ≤1 µL. See the Discussion section for more details on troubleshooting this important aspect of the protocol.
Figure 1: Single-day workflow for the evaluation of promoter parts in cell-free extract. (A) A reporter is PCR-amplified using primers containing genetic parts to be evaluated (2-5 h). (B) The cell-free reaction mix is prepared as detailed in the protocol and distributed into a 384-well plate with the PCR-amplified templates (30 min). (C) Acoustic liquid handling is used to distribute additional components, which can include repressor proteins, effector molecules, and any other conditional effectors (10 min). (D) Reporter protein expression from each reaction is measured in a plate reader (2-16 h, depending on the CFPS recipe and construct). Please click here to view a larger version of this figure.
Figure 2: Primer design for adding genetic parts to a reporter gene by PCR amplification. (A) The sfGFP reporter gene (green) will be amplified to add an RBS (red) and a T7 promoter (blue) by PCR. (B) The sfGFP (green) and an RBS (red) will be amplified to add a tetO sequence (gold) and a T7 promoter (blue) by PCR. Please click here to view a larger version of this figure.
Figure 3: The effect of tetO position on the regulation of a T7-driven expression. Normalized maximum repression values for linear and circular template as a function of tetO position. Traces represent the mean and standard deviations for three replicates. This figure has been modified from McManus et al.32 under a Creative Commons CC-BY license. Please click here to view a larger version of this figure.
Figure 4: Using tartrazine dye to validate liquid dispensing with an acoustic liquid handler. Black bars indicate dispensing 5 µL of tartrazine solution from a single source well into each of the eight consecutive destination wells of a 384-well plate using a single programming command. Gray bars indicate dispensing 1 µL from a single source well into each of eight consecutive destination wells using a single programming command, and then repeating this step four times for a total of 5 µL dispensed in each destination well. Please click here to view a larger version of this figure.
Component Name | Volume for 1 reaction (µL) | Volume for 110% of X number of reactions (µL) |
Q5 PCR Premix | 25 | |
Water | 4 | |
Template (1–3 ng/µL) | 1 | |
(if fixed1) Forward Primer (5 µM) | 0 or 10 | |
(if fixed1) Reverse Primer (5 µM) | 0 or 10 | |
Master Mix Total: | 30 or 40 | |
(if variable1) Forward Primer (5 µM) | 0 or 10 | |
(if variable1) Reverse Primer (5 µM) | 0 or 10 |
Table 1: Worksheet for the preparation of reagents for PCR reactions. Values in the rightmost column can be filled in by users depending on the intended number of reactions. 1Variable primers contain a specific part to be added in the PCR reaction and can be the forward primer, reverse primer, or both. Fixed primers do not add a part and can be the forward primer or reverse primer but not both.
Component Name | Volume for 1 reaction (µL) | Volume for 110% of X number of reactions (µL) |
Cell Extract | 4.2 | |
Supplement Mix | 3.3 | |
GamS Protein (207 µM) | 0.15 | |
Template DNA (20 nM) | 1 | |
T7 Polymerase (13 mg/mL) | 0.12 | |
Water | 0.73 (this number may vary) | |
Master Mix Total: | 9 | |
Repressor Protein: | 1 |
Table 2: Worksheet for the preparation of reagents for CFPS reactions. Values in the rightmost column can be filled in by users depending on the intended number of reactions.
Supplementary Table. Please click here to download this Table.
The protocols described here provide a cost-effective and rapid means to screen genetic parts via the expression of a reporter protein by CFPS. Well-characterized genetic parts are crucial to the design of predictable genetic circuits with useful function. This methodology increases throughput and decreases the time needed to screen new genetic parts by removing the requirement to work in living cells, while retaining functionality that mirrors the cellular environment by retaining the metabolic process of protein expression in the cell lysate. Our protocol can be performed in 1 day after receipt of primers (~2.5-6 h for reaction preparation, 2-16 h for CFPS reaction; Figure 1), compared to at least 3 days for traditional cloning (1 day each for construct assembly and transformation, sequence verification of clones, and culturing of cells for assessment). We further estimate that the cost per construct using linear DNA is roughly one-third of the traditional cloning ($78 vs. $237; Supplementary Table 1) methods. Commercial synthesis services currently quote a minimum of 4 business days depending on size, though they would have similar costs to our method if linear fragments are screened directly in CFPS ($78 vs. $91); we have not verified this approach. The cost to evaluate a part with CFPS is small compared to the generation of the template DNA ($0.05/reaction22 vs. $78 per template), though it should be noted that the startup costs for bulk reagents and lysis equipment is at least several thousand dollars. The use of an acoustic liquid handler only marginally improves costs by enabling smaller volumes down to 0.5 µL40; the more significant advantage is the reduction of time to prepare reactions (~10 min vs. up to 1 h, depending on the number of reactions), especially when preparing a large number of reactions raises concerns of prepared reaction sitting for extended times before incubation.
While rapid and cost-effective, the limitations on when CFPS prototyping adequately predicts in vivo function remain to be seen. For example, any cross-reactivity with genomic DNA will not be detected due to removal of the host genome during the production of the CFPS system. Also, component concentrations can be 1-2 orders of magnitude lower in CFPS than in cells51, which is likely to affect the behavior of some parts as a result of different macromolecular crowding conditions. Further, the ability of linear DNA to predict in vivo function may be limited, for example, when DNA secondary structure plays an important role. A final limitation is that constructs are not sequence-verified before testing for functions. There may be cases where the part characterized is not actually aligned with the intended theoretical sequence. All of these limitations can be mitigated by validating a subset of the parts screened by this method in the intended in vivo application.
We originally developed this methodology to investigate the effects of changing the operator position on hybrid T7-tetO promoters32. We have presented the protocols here in a more generic format, such that they can be applied to promoters, operators, ribosome binding sequences, insulators, and terminators. These genetic parts can be added to the 5ʹ or 3ʹ end of the reporter gene by PCR using primers for each design, obviating the need for synthesis or cloning of each variant to test. The resulting PCR products serve as template DNA for evaluation via the expression of a reporter protein. In our work, the affinity purification protocol provided here was used for TetR and GamS. The same procedure can be used for the expression and purification of other repressors, activators, polymerases, sigma factors, and other proteins cognate to a genetic part of interest, although modifications may be needed for the desired protein being expressed. Purification and titration of these proteins into CFPS reactions enables a more detailed characterization of a particular genetic part. Finally, numerous alternative CFPS protocols exist and each should be amenable to the parts screening portion of methodology. As an example, we do not include a dialysis step in this protocol, which others have found to be important for expression from native bacterial promoters22. Varying the concentrations of underlying constituent components of the CFPS is also possible. The use of liquid handling enhances the ability to test the myriad conditions by increasing throughput and decreasing the materials required34,35.
One area that can require significant troubleshooting is optimization of the acoustic liquid handler. Acoustic liquid handler dispensing should be optimized for each component being transferred and it is strongly recommended to run controls to verify proper distribution and reproducibility before collecting data. The ideal source plate type and liquid class setting will depend on the specific liquid to be dispensed and its components. It is not recommended to use amine-coated plates to dispense DNA, as the amine coating may interact with the DNA. It should also be noted that the ability to dispense higher concentrations of certain components may depend on the acoustic liquid handler model. A test liquid transfer may be conducted by dispensing onto a foil plate seal to visualize successful droplet formation; however, this test provides limited information and droplets from different settings may appear identical. The use of a water-soluble dye, such as tartrazine, may be used to more accurately verify the correct volume is dispensed with a given setting or workflow (see Representative Results). Optimal programming of liquid transfers can also influence the accuracy and consistency of data generated; for transfers >1 µL from one source well to one destination well, we have found that sequential transfers of ≤1 µL should be programmed to reduce systematic well-to-well variability (Figure 4). Lastly, theoretical and actual source well dead volumes can vary dramatically depending on the source plate type, liquid class setting, and components of the specific liquid; using the acoustic liquid handler survey function to assess the well volumes prior to running a program may help gauge how accurately the instrument is able to measure a particular liquid.
CFPS reaction performance can vary when comparing results between different users, batches of materials, plate readers, and laboratories41. For instances where such comparisons are required while prototyping genetic circuits, we recommend including internal control reactions with standard constitutive promoters in each reaction plate to help normalize results across experimental setups. The method of DNA preparation can also contribute majorly to CFPS activity; the inclusion of an ethanol precipitation step is recommended. In addition, the optimal reaction composition can vary by the batch of extract34. Optimal magnesium glutamate and potassium glutamate concentrations, in particular, have been shown to vary by batch42 or with the promoter or reporter protein used24. Concentrations of these components should be optimized by screening across several concentrations of each component per genetic construct and per cell extract preparation to determine the optimal conditions for protein expression. Finally, best practices for consistent CFPS reaction performance include thorough mixing, careful pipetting, and consistency in the preparation of each reagent component.
Beyond characterization of individual parts, the same method can be used to screen combinations of parts that form complex circuits, such as logic circuits16 or oscillators52,53. This method can also be applied to screening and optimizing biosensors for applications in epidemiological diagnostics54,55,56,57 or hazard detection and quantification3,58,59. The application of AI-driven techniques such as active learning34 can also be paired with the high-throughput nature of this method to drive rapid exploration of complex biological design spaces. Ultimately, we envision this approach supporting accelerated development times for new genetic designs in synthetic biology.
The authors have nothing to disclose.
This work was made possible by the Office of the Secretary of Defense's Applied Research for the Advancement of Science and Technology Priorities program. We thank Scott Walper (Naval Research Laboratory) for providing the stock of sfGFP used, and Zachary Sun and Abel Chiao (Tierra Biosciences) for fruitful discussions related to prototyping with cell-free systems and related troubleshooting of acoustic liquid handling.
2x YT medium | Sigma-Aldrich | Y2377-250G | Alternative to making 2xYT media |
Acetic Acid | J.T. Baker | 9508-01 | S30 Buffer B |
Agar | Bacto | 214010 | For plating cells |
Chromatography column (5 cm diameter) | BIO-RAD | 731-1550 | Used for protein purification. |
Destination plate | Thermo Scientific Nunc plate | 142761 | For CFPS reactions |
DMSO | Sigma-Aldrich | D2650 | For dialysis buffer |
DpnI | NEB | R0176L | For digestion of plasmid templates |
DTT | Roche | 20871723 | S30 Buffer B |
E. coli BL21(DE3) Rosetta2 | Novagen | 70954 | Cell line used for production of lysate and purified proteins |
Echo acoustic liquid handler | Labcyte | 525 | Acoustic liquid handler |
French pressure cell | Thermo Spectronic | FA-078 | For lysing cells for CFPS |
Imidazole | Sigma-Aldrich | 56750 | For buffers |
Impermeable plastic sealable lid | Thermo | 232702 | Plate seal |
IPTG | RPI | I56000-25.0 | Used for protein induction. |
K-Glu | Sigma-Aldrich | g1501-500G | S30 Buffer B |
Labcyte Echo source plate | Labcyte | PL-05525 | For use with Echo acoustic liquid handler |
Mg-Glu | Sigma-Aldrich | 49605-250G | S30 Buffer B |
NaCl | Sigma-Aldrich | S7653-250G | For buffers |
NaHPO4 | Sigma-Aldrich | 71505 | For dialysis buffer |
NaOH | Mallinckrodt Chemicals | 7708-10 | For making 2xYT media. Currently not produced by Mallinckrodt. Alternate: Sigma-Aldrich S0899 |
Ni-NTA resin | Invitrogen | R901-15 | For production of purified proteins |
PCR H2O | Ambion | AM9937 | PCR of linear templates |
Plate Reader | BioTek | H10 | Plate reader used |
Q5 PCR Master Mix | NEB | M0494S | PCR of linear templates |
QIAquick Gel Extraction Kit | Qiagen | 28606 | PCR of linear templates |
QIAquick PCR Purification Kit | Qiagen | 28004 | PCR of linear templates |
QSonica Ultrasonic Processor | Qsonica | Q700 | Cell disruption during protein purification |
RTS Amino Acid Sampler | biotechrabbit | BR1401801 | Updated supplier from Sun et al. |
Tris | MP | 819623 | S30 Buffer B |
Tris-Cl | Sigma-Aldrich | T5941 | For buffers |
Tryptone | Fluka | T7293 | For making 2xYT media |
Yeast Extract | Bacto | 212750 | For making 2xYT media |